-
Merck Discontinues MK-3682B and MK-3682C Development Programs
- Source: Mrknewsroom
- 590
- September 30, 2017
-
-
LifeMine Therapeutics combines AI, drug discovery & microbes with $55m launch
- Source: Drugdeliverybusiness
- 459
- September 19, 2017
-
-
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
